Women's Health

Hormonal implants are generally thought to be safe for bone, although whether a young adolescent would reach their genetically determined PBM while using a contraceptive implant is not known.

History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.

New data indicate that a diabetes diagnosis may be associated with earlier onset of menopause.

The move is meant to expand access to reproductive health care for women in the state.

In a recent study, participants who had received a COVID-19 vaccine saw an average increase in menstrual cycle length of less than 1 day.

In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.

The compound may also provide a synergistic effect in combination with fluconazole.

Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.

CBD can be used to treat a myriad of women’s health conditions, but research is still limited.

More women are using medical cannabis for menopause-related symptoms.

New research should give expectant mothers some peace of mind.

Myovant Sciences and Pfizer announces the FDA has approved the therapy for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

This is the first approved therapy targeted to patients with the HER2-low breast cancer subtype. Its approval comes four months ahead of its PDUFA action date.

Oteseconazole treats recurrent vulvovaginal candidiasis in women without reproductive potential.

There are numerous methods of contraception available for adolescents.

Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.

Perrigo’s HRA Pharma has submitted an application to the FDA for possible future approval of the first-ever OTC birth control pill.

Results suggest the potential of this oral therapy to address the unmet clinical need for long-term medical treatment for endometriosis.

The Department of Health and Human Services (HHS) launched a website Friday which offers women a comprehensive list of reproductive health care resources, services, and information.

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.

The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.

Prenatal use of the psychoactive drug benzodiazepines is not a major risk factor for altered neurodevelopment in early childhood, despite crossing the human blood-placenta barrier.

A survey saw that of teenagers who sought care in the ED and were prescribed outpatient treatment, fewer than half who received an STI diagnosis filled their prescriptions.

Vitamins and diet can play a role in the prevention and treatment of uterine fibroids, according to a literature review spanning 20 years published in the journal Nutrients.

In June 2021, ibrexafungerp (Brexafemme; Scynexis) became the first drug approved by the U.S. Food and Drug Administration (FDA) in a novel antifungal class in more than 20 years and is now available to treat vulvovaginal candidiasis (VVC).

Pharmacists can improve quality of life for the women they care for by offering advice, education, and other point-of-care services.

Oteseconazole (Vivjoa) reduces the incidence of recurrent vulvovaginal candidiasis.

Data from a cohort of 5000 patients indicates that NSAID use may negatively effect clodronate therapy in older women.

Between 6% and 10% of women diagnosed with vulvovaginal candidiasis are believed to develop a recurrent form of this condition with 3 to 4 or more episodes in a single year.